Peer Review History
Original SubmissionApril 29, 2020 |
---|
PONE-D-20-12519 Active case-finding policy development, implementation and scale-up in high-burden countries: a mixed-methods survey with National Tuberculosis Programme managers and document review PLOS ONE Dear Olivia, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Tuesday, 14 July 2020. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Hemant Deepak Shewade, MBBS MD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. Additional Editor Comments (if provided): Dear Author (s), Both the reviewers have provided insightful comments. Please go through the comments carefully and address them. The length of the manuscript (>5300 words) might reduce the readership of the article. It will be good if the authors can reduce the number of words in the manuscript. There is scope for reducing the words in methods and discussion section of the article. COVID-19 pandemic associated national lockdowns have disrupted TB services. This has resulted in lockdown associated under-detection of TB. In addition to restoring routine TB services, programmes will have to focus on enhanced and active case finding in high risk populations to detect these people who were missed during lockdown. Please consider discusing the implications of your findings in line with this aspect. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The study explores the attitudes and perception of National TB Programme managers related to the ACF policy development, implementation and scale-up plan provides a good insight on ACF implementation. Also, this manuscript provides a fair idea about the process and actors of policy development and implementation of any newer TB control strategy. Thus, the information from this study could be of help to successfully advocate for adoption of newer strategies like TB preventive therapy for household contacts in high-burden countries. The authors have managed to comprehensively explore the ACF implementation by adopting mixed-methods design and also including the review of NSPs. Though, I completely acknowledge the vastness and scope of this research work, the manuscript requires is quite lengthy (>5000 words) and requires to be trimmed. There is scope for reducing some words in the manuscript especially in methods and discussion section of the manuscript. Though, in mixed-methods studies, it is difficult to avoid completely the repetition of information between results and discussion, some of it can be deleted from discussion (Line number 479-482) Below are some specific minor comments. Abstract 1. In the results section, the component headings like 'Scale-up of ACF' and 'ACF policy development and implementation' can be removed. The results section can be rewritten in the same sequence of ACF policy development, implementation and scale-up, as mentioned in the objectives. 2. The conclusion section can also highlight the need for future operational research to generate local evidence on ACF for policy development. Introduction: 1. Line 72: You can be explicitly state that about 3 million TB patients were either undetected or undetected but not notified. Also, this estimate of 3 million corresponds to 2018, as the WHO global report of 2019 provides estimates of 2018. Please check. 2. The information on high TB burden countries mentioned in the second paragraph does not give the importance of these countries in line with missing TB patients and also the ACF policy. Thus, it breaks the flow of the introduction. The authors can consider shifting this paragraph just before the aim of the study. Also, can justify the reason for considering only the high TB burden countries. 3. Line 86: I feel the authors can quote here some of the specific research studies which assessed the benefits and challenges of the ACF. I have listed some below. 1. Marks GB, Nguyen NV, Nguyen PTB, et al. Community-wide Screening for Tuberculosis in a High-Prevalence Setting. N Engl J Med. 2019;381(14):1347‐1357. doi:10.1056/NEJMoa1902129 2. Shewade HD, Kumar AMV, Satyanarayana S, et al. Benefits of community-based TB screening vs. passive case finding. Int J Tuberc Lung Dis. 2020;24(4):464‐465. doi:10.5588/ijtld.19.0744 3. Shewade H D, Gupta V, Satyanarayana S, et al. Patient characteristics, health seeking and delays among new sputum smear positive TB patients identified through active case finding when compared to passive case finding in India. PLoS One 2019; 14: e0213345 4. Shewade H D, Gupta V, Satyanarayana S, et al. Active case finding among marginalised and vulnerable populations reduces catastrophic costs due to tuberculosis diagnosis. Glob Health Action 2018; 11: 1494897. 5. Shamanewadi AN, Naik PR, Thekkur P, et al. Enablers and Challenges in the Implementation of Active Case Findings in a Selected District of Karnataka, South India: A Qualitative Study. Tuberc Res Treat. 2020;2020:9746329. Published 2020 Jan 24. doi:10.1155/2020/9746329 6. Dey A, Thekkur P, Ghosh A, et al. Active Case Finding for Tuberculosis through TOUCH Agents in Selected High TB Burden Wards of Kolkata, India: A Mixed Methods Study on Outcomes and Implementation Challenges. Trop Med Infect Dis. 2019;4(4) Methods: 1. The authors needs to provide reference for the embedded study design as design adopted here doesn't clearly fit into the classical embedded mixed-methods designs. There are two different components- Survey (with quantitative variables and descriptive details for few questions (considered as qualitative)) plus Review of documents. Please provide the reference if the current design is documented in detail elsewhere. 2. Line 110: Were the interviews were always structured? No probes were used to explore more on the issues, when the participants tried to explain their selections (?qualitative data)? Whether this type of interviewing might have limited the exploration on a particular phenomenon? 3. Line 178: Whether second attempt was not made to complete the interview when the interview was discontinued due to bad connection? 4. Line 181: Whether the interviews conducted in English language might have limited the information from the NTP managers of non-native English speaking countries? 5. Line 189: What is the reason for conducting interviews in different settings and mode of communication. Was it based on the convenience of the NTP managers or the investigators? Could this difference in data collection influenced the data obtained? 6. Who conducted the interviews and what was the average duration of these interviews. What proportion of the NTP managers responded to the mail request for validating their responses? Results: 1. There is lack of consistency in reporting of the numbers and percentages. Sometimes, the percentages are mentioned in words and a few times in numbers. The authors can be consistent in reporting. 2. Line 262: It would be better the mention 'Among the 20 participants who identified themselves either as policymakers or “other”,' instead of 'Among those who identified themselves 262 either as policymakers or “other”,'. The later requires the reader to back calculate the denominator. 3. Line 271: It is important to objectively highlight that the lower percentage agreed for improved treatment outcomes, reduced future health system cost and positive social and economic consequences for TB patient. 4. Line 284: The authors can highlight the lack of agreement or disagreement related to potential 5. Line 361: The heading can be replaced as 'Source of evidence and reference materials for ACF policy-making' 6. Line 401: What does 'national policymakers' mean? Is it policy makers in general health system or the governments? Need clarity. Discussion: 1. There is quite a bit of repetition from the results. The authors can try to reduce the content in the discussion section. 2. The summary paragraph (first paragraph) can be aligned with the objectives- Policy development, implementation and scale-up. 3. Some of the limitations related to qualitative exploration with structured questionnaire and use of English language for interview could be mentioned. Reviewer #2: General comments The authors of this study used a detailed cross-sectional survey administered to 30 high TB burden country’s National Tuberculosis Program (NTP) managers to qualitatively and quantitatively assess policy development, implementation, and scale-up of TB active case finding (ACF). The authors reported that a majority of NTP mangers responded (73%). Survey results highlighted that NTP managers in high burden countries acknowledge the importance of ACF intervention in addressing gaps in TB care, but reported that they face a range of political, resource (including financial), and infrastructural gaps in effectively developing relevant policies, implementing and scaling-up ACF interventions. Evidence from this study can be useful in understanding the current state of NTP decision-making process for ACF and gaps in important policy-relevant evidence that can facilitate effective policy development and implementation of ACF interventions. As such, this reviewer feels that the study provides important information for both the TB researchers and the general public (many of issues that are faced by the NTP managers are akin to the policy development and implementation of many of public health interventions in the resource-poor settings). Points to address in the revision While the study is useful in understanding the perspectives of NTP mangers (high-level officials), this in itself is the main limitation of the study. This reviewer acknowledges that the survey design and target respondents are appropriate for the primary focus of this study – conducting a scoping review of high-level factors that influence policy development and implementation/scale-up of active case finding for TB in each country – future studies using similar types of survey method focusing on lower-level officials and local programmatic officers who work much more closely at the field, district, and facility-level may provide important programmatic hurdles in implementing ACF interventions. For example, resource needs, infrastructural challenges faced in different operational settings within a country may vary significantly and these can directly influence how ACF interventions are designed and optimized for their operations, costs, and cost-effectiveness. This reviewer would appreciate it if the authors dedicate a section in the discussion section on this matter (expand a bit in their “Future research” section). The authors were able to get responses from 23 NTP mangers in this study. Were there certain patterns of responses that may be associated with the policy/health systems/economic indicators of the country of each respondent (see if these have any correlation to the macro-level policy/public health/economic indicator of each country)? The reviewer understands that the study is not powered to investigate such correlations statistically but would be very useful to report on these patterns of responses (e.g. regions, TB burden, NTP budget levels reported to the WHO etc.). For example, NTP mangers in countries where the NTP budget may be highly constrained (and have higher dependency on foreign funding) may have completely different perspective (and therefore, different response to the survey questions) than those with better financial situation. Also, there are countries with very specific ACF (and contact investigation) policies, but due to resource and infrastructural constraints, actual programs may not be adequately operating. Do responses from these NTP mangers (their understanding of existence of these policies and programmatic limitations) match what’s been reported in the public (via policy documents, WHO statements, etc.)? The authors also state in their limitations (Lines 568 - 575) that participant responses may be affected by the mood state bias. Can the authors provide which of the survey questions may be most affected by this bias and how future research (e.g. if the authors were to conduct this study again, what would they do to reduce this bias?) can improve upon this issue? Also, it would be important to mention in the study limitations (or anywhere else in the discussion section) that policy/implementation/scale-up issues for ACF may be unique to situations (political, financial, and infrastructural) faced in each country. Therefore, similar types of (improved to include additional questions relevant to the country/setting) survey administered in each country to identify challenges and potential strategies in developing policies, implementing and scaling up ACF interventions would be very important. It would be useful for the authors to mention this as part of their future direction for research. Based on reporting of the survey results in Figures S3 and 4, this reviewer has one major concern for the survey design. These findings would be been much more useful (again this is my personal opinion and other reviewers may have different perspectives on this matter) if the authors asked the NTP managers to rank each component for the risk factors for ACF and use of evidence in policy making for ACF. For example, it looks clear from Figure S3 that most of the NTP managers feel that increased health systems cost (short-term) is the main perceived risk for ACF intervention, followed by ‘increased worry about health’ and ‘stigma’. Current presentation of survey results in these two figures are a bit difficult to comprehend. Minor suggestions Figure S1. Please provide sub-titles describing each of the process a bit more in detail so that readers can have a good understanding just by reviewing the figure and the sub-title itself. Table 1: It would be good to have a full version of such table presented in the appendix to show the process of developing the survey (this would be very helpful for other researchers to use this study in developing similar types of survey for other disease or for TB within the country) In Figure S2 (Policy analysis triange), it would be very important to provide sub-text/title for each content of the triangle. For example, it’s not clear from just reviewing the figure itself how these components interact with one another. To this reviewer, a policy triangle is better represented as a process diagram showing how each component interacts with one another and describing the contents of each triangle. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Hojoon Sohn [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
PONE-D-20-12519R1 Active case-finding policy development, implementation and scale-up in high-burden countries: a mixed-methods survey with National Tuberculosis Programme managers and document review PLOS ONE Dear Olivia, Kindly resubmit. The response to review comments is not formatted well enough to differentiate between reviewer comment and author resposne. I suggest this Mention in capital REVIEWER COMMENT before a reviewer comment and then follow it up with AUTHOR RESPONSE in capital before providing a response. Give a line space between one set of REVIEWER COMMENT and AUTHOR RESPONSE. Do this uniformly throughout the response to reviewer comment file. In the author response, please mention the exact line where the edits have been made in the revised mansucript with track changes. Please resubmit by 10 Aug 2020. Kind regards, Hemant Deepak Shewade, MBBS MD Academic Editor PLOS ONE |
Revision 2 |
Active case-finding policy development, implementation and scale-up in high-burden countries: a mixed-methods survey with National Tuberculosis Programme managers and document review PONE-D-20-12519R2 Dear Ms Biermann, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hemant Deepak Shewade, MBBS MD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The evidence generated through this research would enable the policy makers of NTPs to reflect on the process they follow in making decisions. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Pruthu Thekkur |
Formally Accepted |
PONE-D-20-12519R2 Active case-finding policy development, implementation and scale-up in high-burden countries: a mixed-methods survey with National Tuberculosis Programme managers and document review Dear Dr. Biermann: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Hemant Deepak Shewade Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .